Verition Fund Management LLC Logic Bio Therapeutics, Inc. Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.61 - $2.49 $69,254 - $282,694	-113,532 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.85 - $5.09 $364,082 - $481,346	-94,567 Reduced 45.44%	113,532 $520,000
Q2 2021 Aug 16, 2021	SELL	$4.03 - $7.57 $76,029 - $142,815	-18,866 Reduced 8.31%	208,099 $924,000
Q1 2021 May 18, 2021	SELL	$6.8 - $9.16 $19,509 - $26,280	-2,869 Reduced 1.25%	226,965 $1.65 Million
Q4 2020 Feb 16, 2021	BUY	$5.29 - $9.1 $1.22 Million - $2.09 Million	229,834 New	229,834 $1.75 Million

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.